Kang Cheng

2.6k citations
70 papers · 1.9k indexed · h-index 26

Kang Cheng

67 papers receiving 1.8k citations

Peers

Kang Cheng
Comparison fields: 5 of 104
  • Biochemistry 192
  • Endocrinology, Diabetes and Metabolism 322
  • Reproductive Medicine 157
  • Endocrine and Autonomic Systems 107
  • Organic Chemistry 428
Replace Robert J. DeVita with:
Robert J. DeVita United States
Dale E. Mais United States
Richard Saperstein United States
Montserrat Miralpeix Spain
S. Nicosia Italy
Raymond F. Kauffman United States
Alex M. Nadzan United States
K.W. Nettles United States
Arco Y. Jeng United States
Wanda Chan United States
Kang Cheng relative to Robert J. DeVita United States Robert J. DeVita's profile →
Citations per field
00.5×1.5×2.0×
Robert J. DeVita · 1×
Citations per year

Countries citing papers authored by Kang Cheng

Since Specialization
Citations

This map shows the geographic impact of Kang Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang Cheng more than expected).

Fields of papers citing papers by Kang Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kang Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang Cheng. The network helps show where Kang Cheng may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kang Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kang Cheng Line = papers co-authored together Kang Cheng links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20230
3 202317
4 202239
5 202037
6 201739
7 201017
8 201010
9 200928
10 200910
11 200913
12 200820
13 200716
14 200418
15 20035
16 200212
17 200116
18 199928
19 199953
20 198062

About Kang Cheng

Kang Cheng is a scholar working on Reproductive Medicine, Biochemistry and Molecular Biology, having authored 70 papers that have together received 1.9k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (11 papers), Receptor Mechanisms and Signaling (11 papers), Chemical Synthesis and Analysis (8 papers), Hypothalamic control of reproductive hormones (8 papers), Pancreatic function and diabetes (8 papers), Growth Hormone and Insulin-like Growth Factors (7 papers), Catalytic C–H Functionalization Methods (4 papers) and Mitochondrial Function and Pathology (4 papers). The work is most often cited by research in Biochemistry (192 citations), Endocrinology, Diabetes and Metabolism (322 citations) and Reproductive Medicine (157 citations). Kang Cheng has collaborated with scholars based in United States, China and Czechia. Frequent co-authors include Joseph Larner, Gail Galasko, Laura C. Huang, Roy G. Smith, Mark T. Goulet, M. Gerard Waters, Matthew J. Wyvratt, Michael H. Fisher, Tsuei-Ju Wu and Kenneth K. Wu. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026